Sathish Kumar Ganesan
Overview
Explore the profile of Sathish Kumar Ganesan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sidiropoulos D, Rafie C, Jang J, Castanon S, Baugh A, Gonzalez E, et al.
Cancer Immunol Res
. 2022 Feb;
10(5):656-669.
PMID: 35201318
Therapeutic combinations to alter immunosuppressive, solid tumor microenvironments (TME), such as in breast cancer, are essential to improve responses to immune checkpoint inhibitors (ICI). Entinostat, an oral histone deacetylase inhibitor,...
2.
Klotz R, Thomas A, Teng T, Han S, Iriondo O, Li L, et al.
Cancer Discov
. 2019 Oct;
10(1):86-103.
PMID: 31601552
Hematogenous metastasis is initiated by a subset of circulating tumor cells (CTC) shed from primary or metastatic tumors into the blood circulation. Thus, CTCs provide a unique patient biopsy resource...
3.
Zhao H, Gulesserian S, Ganesan S, Ou J, Morrison K, Zeng Z, et al.
Mol Cancer Ther
. 2017 Jun;
16(9):1877-1886.
PMID: 28655784
Thrombocytopenia is a common adverse event in cancer patients treated with antibody-drug conjugates (ADC), including AGS-16C3F, an ADC targeting ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase-3) and trastuzumab emtansine (T-DM1). This study aims to...
4.
Zhao H, Gulesserian S, Malinao M, Ganesan S, Song J, Chang M, et al.
Mol Cancer Ther
. 2017 May;
16(9):1866-1876.
PMID: 28522588
Neutropenia is a common adverse event in cancer patients treated with antibody-drug conjugates (ADC) and we aimed to elucidate the potential mechanism of this toxicity. To investigate whether ADCs affect...
5.
Kang J, Ramu S, Lee S, Aguilar B, Ganesan S, Yoo J, et al.
Anal Biochem
. 2009 Jan;
386(2):251-5.
PMID: 19150324
Although various nonviral transfection methods are available, cell toxicity, low transfection efficiency, and high cost remain hurdles for in vitro gene delivery in cultured primary endothelial cells. Recently, unprecedented transfection...